@Article{Dekker2022,
journal="Pediatric Endocrinology Diabetes and Metabolism",
issn="2081-237X",
volume="28",
number="1",
year="2022",
title="Jakie metody oznaczania C-peptydu powinnyśmy stosować?",
abstract="Many C-peptide assays are commercially available for research and routine use. However, not all assays yield consistent results, especially in the low concentration ranges. We searched the literature describing C-peptide measurements to assess which assays are mainly used in the diabetes research field and if they are specified. Percentages of publications on C-peptide measurements in type 1 diabetes (T1D), type 2 diabetes (T2D) and other forms of diabetes were 32%, 54% and 14%, respectively. In only 54% of the publications the used assay was specified. Information on detection limit, measurement range and variation was provided in 12%, 2% and 11% of publications, respectively. In 22% of all publications no C-peptides concentrations were mentioned. This may be a problem especially for T1D research, where measuring very low levels of C-peptide is becoming increasingly important and concordance between assays is low.",
author="Dekker, Pim
and de Vries, Martine
and Aanstoot, Henk-Jan
and Groen, Joost",
pages="101--103",
doi="10.5114/pedm.2022.113741",
url="http://dx.doi.org/10.5114/pedm.2022.113741"
}